Low-grade dysplasia in ulcerative colitis: risk factors for developing high-grade dysplasia or colorectal cancer - PubMed (original) (raw)
. 2015 Oct;110(10):1461-71; quiz 1472.
doi: 10.1038/ajg.2015.248. Epub 2015 Sep 29.
Affiliations
- PMID: 26416190
- PMCID: PMC4697133
- DOI: 10.1038/ajg.2015.248
Low-grade dysplasia in ulcerative colitis: risk factors for developing high-grade dysplasia or colorectal cancer
Chang-ho Ryan Choi et al. Am J Gastroenterol. 2015 Oct.
Abstract
Objectives: The aim of this study was to identify risk factors associated with development of high-grade dysplasia (HGD) or colorectal cancer (CRC) in ulcerative colitis (UC) patients diagnosed with low-grade dysplasia (LGD).
Methods: Patients with histologically confirmed extensive UC, who were diagnosed with LGD between 1993 and 2012 at St Mark's Hospital, were identified and followed up to 1 July 2013. Demographic, endoscopic, and histological data were collected and correlated with the development of HGD or CRC.
Results: A total of 172 patients were followed for a median of 48 months from the date of initial LGD diagnosis (interquartile range (IQR), 15-87 months). Overall, 33 patients developed HGD or CRC (19.1% of study population; 20 CRCs) during study period. Multivariate Cox proportional hazard analysis revealed that macroscopically non-polypoid (hazard ratio (HR), 8.6; 95% confidence interval (CI), 3.0-24.8; P<0.001) or invisible (HR, 4.1; 95% CI, 1.3-13.4; P=0.02) dysplasia, dysplastic lesions ≥1 cm in size (HR, 3.8; 95% CI, 1.5-13.4; P=0.01), and a previous history of "indefinite for dysplasia" (HR, 2.8; 95% CI, 1.2-6.5; P=0.01) were significant contributory factors for HGD or CRC development. Multifocal dysplasia (HR, 3.9; 95% CI, 1.9-7.8; P<0.001), metachronous dysplasia (HR, 3.5; 95% CI, 1.6-7.5; P=0.001), or a colonic stricture (HR, 7.4; 95% CI, 2.5-22.1; P<0.001) showed only univariate correlation to development of HGD or CRC.
Conclusions: Lesions that are non-polypoid or endoscopically invisible, large (≥1 cm), or preceded by indefinite dysplasia are independent risk factors for developing HGD or CRC in UC patients diagnosed with LGD.
Figures
Figure 1
Lesion shape categorization. Discrete sessile, (a) pedunculated (b), or sub-pedunculated lesions (c) that were well circumscribed from the surrounding mucosa were classifi ed as “polypoid” LGD. Superfi cially raised (d and e), visible fl at (f), irregular, or plaque-like lesions were classifi ed as “nonpolypoid” LGD.
Figure 2
Kaplan–Meier plots showing cumulative risk of developing high-grade dysplasia (HGD) or colorectal cancer (CRC). (a) Overall cumulative risk. (b) Cumulative risk by low-grade dysplasia (LGD) lesion shape. (c) Cumulative risk by LGD lesion size. (d) Cumulative risk depending on the presence or absence of preceding indefinite dysplasia.
Figure 3
Kaplan–Meier plot showing the cumulative risk of high-grade dysplasia (HGD) or colorectal cancer (CRC) development depending on total number of risk factors present (i.e., any combinations of nonpolypoid or invisible low-grade dysplasia (LGD), LGD sized ≥1 cm, and/or preceding indefinite dysplasia).
Comment in
- Clarity and caution in the natural history of low-grade dysplasia in ulcerative colitis.
Kisiel JB, Loftus EV. Kisiel JB, et al. Am J Gastroenterol. 2015 Oct;110(10):1473-4. doi: 10.1038/ajg.2015.315. Am J Gastroenterol. 2015. PMID: 26465907 Free PMC article.
Similar articles
- Progression of low-grade dysplasia to advanced neoplasia based on the location and morphology of dysplasia in ulcerative colitis patients with extensive colitis under colonoscopic surveillance.
Navaneethan U, Jegadeesan R, Gutierrez NG, Venkatesh PG, Hammel JP, Shen B, Kiran RP. Navaneethan U, et al. J Crohns Colitis. 2013 Dec;7(12):e684-91. doi: 10.1016/j.crohns.2013.06.006. Epub 2013 Jul 31. J Crohns Colitis. 2013. PMID: 23916526 - Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
Venkatesh PG, Jegadeesan R, Gutierrez NG, Sanaka MR, Navaneethan U. Venkatesh PG, et al. J Crohns Colitis. 2013 Dec;7(12):968-73. doi: 10.1016/j.crohns.2013.02.002. Epub 2013 Feb 20. J Crohns Colitis. 2013. PMID: 23433613 - Progression of low-grade dysplasia in ulcerative colitis: effect of colonic location.
Goldstone R, Itzkowitz S, Harpaz N, Ullman T. Goldstone R, et al. Gastrointest Endosc. 2011 Nov;74(5):1087-93. doi: 10.1016/j.gie.2011.06.028. Epub 2011 Sep 10. Gastrointest Endosc. 2011. PMID: 21907984 - Dysplasia in ulcerative colitis--clinical consequences?
Sjöqvist U. Sjöqvist U. Langenbecks Arch Surg. 2004 Oct;389(5):354-60. doi: 10.1007/s00423-003-0455-6. Epub 2004 Mar 13. Langenbecks Arch Surg. 2004. PMID: 15605166 Review. - Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis.
Thomas T, Abrams KA, Robinson RJ, Mayberry JF. Thomas T, et al. Aliment Pharmacol Ther. 2007 Mar 15;25(6):657-68. doi: 10.1111/j.1365-2036.2007.03241.x. Aliment Pharmacol Ther. 2007. PMID: 17311598 Review.
Cited by
- Targeted Sequencing of Cytokine-Induced PI3K-Related Genes in Ulcerative Colitis, Colorectal Cancer and Colitis-Associated Cancer.
Razali NN, Raja Ali RA, Muhammad Nawawi KN, Yahaya A, Mokhtar NM. Razali NN, et al. Int J Mol Sci. 2022 Sep 29;23(19):11472. doi: 10.3390/ijms231911472. Int J Mol Sci. 2022. PMID: 36232773 Free PMC article. - Chromoendoscopy with targeted biopsies is superior to white-light endoscopy for the long-term follow-up detection of dysplasia in ulcerative colitis patients: a multicenter randomized-controlled trial.
Wan J, Zhang Q, Liang SH, Zhong J, Li JN, Ran ZH, Zhi FC, Wang XD, Zhang XL, Wen ZH, Sheng JQ, Shi HX, Mei Q, Wu KC. Wan J, et al. Gastroenterol Rep (Oxf). 2020 Sep 20;9(1):14-21. doi: 10.1093/gastro/goaa028. eCollection 2021 Jan. Gastroenterol Rep (Oxf). 2020. PMID: 33747522 Free PMC article. - SRC and TP53 play critical role in low-grade dysplasia colorectal mucosa transformation into cancer.
Asadzadeh-Aghdaei H, Zamanian Azodi M, Vafaee R, Moravvej Farshi H, Naderi N. Asadzadeh-Aghdaei H, et al. Gastroenterol Hepatol Bed Bench. 2018 Winter;11(Suppl 1):S104-S110. Gastroenterol Hepatol Bed Bench. 2018. PMID: 30774815 Free PMC article. - Colitis-Associated Dysplasia in Inflammatory Bowel Disease: Features and Endoscopic Management.
Schiavone SC, Biancone L, Fiorillo M, Divizia A, Mancone R, Neri B. Schiavone SC, et al. Cancers (Basel). 2025 Feb 25;17(5):784. doi: 10.3390/cancers17050784. Cancers (Basel). 2025. PMID: 40075631 Free PMC article. Review. - ATG10-dependent autophagy is required for DDX10 to regulate cell proliferation, apoptosis and stemness in colorectal cancer.
Wang K, Zhan H, Fan S, Chu S, Xu H, Jiang H. Wang K, et al. J Cancer Res Clin Oncol. 2024 Aug 7;150(8):386. doi: 10.1007/s00432-024-05910-3. J Cancer Res Clin Oncol. 2024. PMID: 39110225 Free PMC article.
References
- 1Ullman T, Croog V, Harpaz N et al. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology 2003;5085:1311–1319. - PubMed
- 2Bernstein C, Shanahan F, Weinstein W. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet 1994, 71–75. - PubMed
- 3Blackstone MO, Riddell RH, Rogers BH et al. Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. Gastroenterology 1981;80:366–374. - PubMed
- 4Befrits R, Ljung T, Jaramillo E et al. Low-grade dysplasia in extensive, long-standing inflammatory bowel disease: a follow-up study. Dis Colon Rectum 2002;45:615–620. - PubMed
- 5Jess T, Loftus EV, Velayos FS et al. Incidence and prognosis of colorectal dysplasia in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota. Inflamm Bowel Dis 2006;12:669–676. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical